NCT00002403View on ClinicalTrials.gov

Safety and Effectiveness of Zintevir (AR177) Given to HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Zintevir

Trial Locations (1)

10021

Cornell AIDS Clinical Trials Unit, New York

Sponsors
All Listed Sponsors
lead

Aronex Pharmaceuticals

INDUSTRY